BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tacke F, Schöffski P, Luedde T, Meier PN, Ganser A, Manns MP, Trautwein C. Analysis of factors contributing to higher erythropoietin levels in patients with chronic liver disease. Scand J Gastroenterol. 2004;39:259-266. [PMID: 15074396 DOI: 10.1080/00365520310008340] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Tacke F, Luedde T, Manns MP, Trautwein C. Regulation of plasma erythropoietin in chronic liver disease. World J Gastroenterol 2004; 10(19): 2922-2923 [PMID: 15334703 DOI: 10.3748/wjg.v10.i19.2922] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
2 Bruno CM, Sciacca C, Cilio D, Bertino G, Pellicano R. Erythropoietin in liver cirrhosis: Two questions without answers. World J Gastroenterol 2005; 11(23): 3649-3649 [PMID: 15962396 DOI: 10.3748/wjg.v11.i23.3649] [Cited by in CrossRef: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Alsaran KA, Sabry AA, Alghareeb AH, Al Sadoon G. Effect of Hepatitis C Virus on Hemoglobin and Hematocrit Levels in Saudi Hemodialysis Patients. Renal Failure 2009;31:349-54. [DOI: 10.1080/08860220902835855] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
4 Lin Y, Lin C, Lee C, Lai I, Chen H, Chen T. Chronic hepatitis ameliorates anaemia in haemodialysis patients. Nephrology 2008;13:289-93. [DOI: 10.1111/j.1440-1797.2008.00937.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
5 Ramadori P, Sheikh N, Ahmad G, Dudas J, Ramadori G. Hepatic changes of erythropoietin gene expression in a rat model of acute-phase response. Liver Int 2010;30:55-64. [PMID: 19840250 DOI: 10.1111/j.1478-3231.2009.02131.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
6 Mahar KM, Shaddinger BC, Ramanjineyulu B, Andrews S, Caltabiano S, Lindsay AC, Cobitz AR. Pharmacokinetics of Daprodustat and Metabolites in Individuals with Normal and Impaired Hepatic Function. Clin Pharmacol Drug Dev 2022. [PMID: 35355447 DOI: 10.1002/cpdd.1090] [Reference Citation Analysis]
7 Sigal M, Siebert N, Zechner D, Menschikow E, Abshagen K, Vollmar B, Eipel C. Darbepoetin-α inhibits the perpetuation of necro-inflammation and delays the progression of cholestatic fibrosis in mice. Lab Invest 2010;90:1447-56. [PMID: 20567234 DOI: 10.1038/labinvest.2010.115] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
8 Siciliano M, Annicchiarico BE, Franceschelli A. Erythropoietin secretion in patients with liver cirrhosis. Scandinavian Journal of Gastroenterology 2009;40:122-3. [DOI: 10.1080/003655205100012334] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Tacke F, Wüstefeld T, Horn R, Luedde T, Srinivas Rao A, Manns MP, Trautwein C, Brabant G. High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo. Journal of Hepatology 2005;42:666-73. [DOI: 10.1016/j.jhep.2004.12.024] [Cited by in Crossref: 90] [Cited by in F6Publishing: 92] [Article Influence: 5.3] [Reference Citation Analysis]
10 Bonnas C, Wüstefeld L, Winkler D, Kronstein-Wiedemann R, Dere E, Specht K, Boxberg M, Tonn T, Ehrenreich H, Stadler H, Sillaber I. EV-3, an endogenous human erythropoietin isoform with distinct functional relevance. Sci Rep 2017;7:3684. [PMID: 28623280 DOI: 10.1038/s41598-017-03167-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
11 Tacke F, Liedtke C, Bocklage S, Manns MP, Trautwein C. CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter. Gut 2005;54:1309-17. [PMID: 15871998 DOI: 10.1136/gut.2005.065086] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.2] [Reference Citation Analysis]
12 Bladé JS, Desramé J, Corberand D, Lecoules S, Blondon H, Carmoi T, Zyani M, Béchade D, Algayres JP. [Diagnosis of anemia in alcoholic cirrhosis]. Rev Med Interne 2007;28:756-65. [PMID: 17559980 DOI: 10.1016/j.revmed.2007.05.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
13 Tacke F, Fiedler K, von Depka M, Luedde T, Hecker H, Manns MP, Ganser A, Trautwein C. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease. Liver Int. 2006;26:173-181. [PMID: 16448455 DOI: 10.1111/j.1478-3231.2005.01205.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]